NCT06649474
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +14 more
- Locations
-
- CHU Estaing de Clermont-Ferrand Clermont-Ferrand, France
Clinical trial condition
Resectable Esophageal Cancer
Explore clinical trials studying Resectable Esophageal Cancer. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Resectable Esophageal Cancer trial results
Not Yet Recruiting
Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC
NCT07385664
- Conditions
- Resectable Esophageal Cancer
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
Completed
Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer
NCT03490292
- Conditions
- GastroEsophageal Cancer, Resectable Esophageal Cancer
- Locations
-
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
NCT01858805
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +12 more
- Locations
-
- University Hospital Hamburg-Eppendorf Hamburg, Germany
Active, Not Recruiting
Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection
NCT05307835
- Conditions
- Resectable Esophageal Cancer
- Locations
-
- The Second Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China